Venlo, the Netherlands, Nov. 09, 2023 (GLOBE NEWSWIRE) -- QIAGEN (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three new kits for use on its QIAcuity systems and a ...
Firm will seek approval of a range of diagnostic assays for the platform. Qiagen confirmed the receipt or FDA 510(k) clearance for both its Rotor-Gene Q MDx real-time PCR platform, and also the artus ...
QIAGEN N.V. QGEN recently announced that its consumables kits have been used to process more than 3 billion biological samples. This milestone underlines QIAGEN’s leading position in sample ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results